Requires Adobe Acrobat ReaderRequires Adobe Acrobat Reader| Year of Transplant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | ||
| Functioning Graft at Discharge | 3,928 | 4,093 | 4,322 | 4,571 | 4,778 | 5,120 | 5,622 | 5,863 | 6,128 | 6,005 | |
| With Immunosuppression Info | 3,742 | 3,943 | 4,304 | 4,564 | 4,774 | 5,114 | 5,594 | 5,792 | 6,062 | 5,902 | |
| Corticosteroids | Any in Category | 94.5% | 93.0% | 91.9% | 90.2% | 90.4% | 82.4% | 80.6% | 78.9% | 78.4% | 75.9% |
| Steroids | 94.5% | 93.0% | 91.9% | 90.2% | 90.4% | 82.4% | 80.6% | 78.9% | 78.4% | 75.9% | |
| Cyclosporine | Any in Category | 31.1% | 25.9% | 18.5% | 11.9% | 10.2% | 8.7% | 8.1% | 7.0% | 6.7% | 7.2% |
| Cyclosporin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | |
| Sandimmmune | 4.0% | 3.8% | 3.1% | 1.3% | 1.1% | 0.4% | 0.5% | 0.6% | 0.8% | 0.9% | |
| Neoral | 27.0% | 22.1% | 15.3% | 9.7% | 7.4% | 7.4% | 6.6% | 5.6% | 4.3% | 5.1% | |
| Gengraf | 0.0% | 0.0% | 0.1% | 0.6% | 1.5% | 0.8% | 0.8% | 0.6% | 1.0% | 0.8% | |
| Eon | 0.0% | 0.0% | 0.0% | 0.4% | 0.2% | 0.1% | 0.2% | 0.1% | 0.5% | 0.3% | |
| Tacrolimus | Any in Category | 67.1% | 71.6% | 76.6% | 83.1% | 86.8% | 88.8% | 88.7% | 90.8% | 91.3% | 90.7% |
| Tacrolimus | 67.1% | 71.6% | 76.6% | 83.1% | 86.8% | 88.8% | 88.7% | 90.8% | 91.3% | 90.7% | |
| Antimetabolites | Any in Category | 42.1% | 44.5% | 48.3% | 50.8% | 51.6% | 57.3% | 58.3% | 61.4% | 69.1% | 72.8% |
| Mycophenolate Mofetil | 30.3% | 36.7% | 43.3% | 47.7% | 48.1% | 54.1% | 55.8% | 58.5% | 65.0% | 67.2% | |
| Mycophenolate Sodium | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.4% | 2.1% | 3.7% | 4.9% | |
| Azathioprine | 11.6% | 7.7% | 5.0% | 3.0% | 3.5% | 3.2% | 2.1% | 0.7% | 0.4% | 0.6% | |
| Leflunomide | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Cytoxan | 0.2% | 0.1% | 0.0% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| mTOR Inhibitors | Any in Category | 0.8% | 0.6% | 9.4% | 9.9% | 6.6% | 4.4% | 4.9% | 4.0% | 3.7% | 2.5% |
| Sirolimus | 0.8% | 0.5% | 9.4% | 9.9% | 6.6% | 4.4% | 4.9% | 4.0% | 3.7% | 2.5% | |
| Everolimus | 0.0% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
Requires Adobe Acrobat Reader